BSE Live
Nov 28, 13:43Prev. Close
2248.95
Open Price
2249.65
Bid Price (Qty.)
2248.45 (1)
Offer Price (Qty.)
2251.05 (24)
NSE Live
Nov 28, 13:43Prev. Close
2249.30
Open Price
2259.80
Bid Price (Qty.)
2248.40 (1)
Offer Price (Qty.)
2249.50 (41)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,264.92 | 691.30 | 932.77 | 781.61 | 673.65 | |
| Net CashFlow From Operating Activities | 959.61 | 536.52 | 860.12 | 506.95 | 482.54 | |
| Net Cash Used In Investing Activities | -395.68 | -305.58 | -836.39 | -513.06 | -99.95 | |
| Net Cash Used From Financing Activities | -558.91 | -239.81 | 7.71 | -1.41 | -362.74 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 5.02 | -8.87 | 31.44 | -7.52 | 19.85 | |
| Cash And Cash Equivalents Begin of Year | 72.48 | 81.35 | 49.91 | 57.44 | 51.96 | |
| Cash And Cash Equivalents End Of Year | 77.50 | 72.48 | 81.35 | 49.91 | 71.81 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y